India, Nepal strengthen health cooperation at WHA78 bilateral meeting in Geneva
The meeting, held between India's Health Secretary Punya Salila Srivastava and Nepal's Minister of Health and Population Pradip Paudel, focused on key health issues such as affordable drugs, communicable and non-communicable diseases (NCDs), digital health, and capacity building of the health workforce.
'A bilateral meeting took place today on the sidelines of #WHA78 between Health Secretary, Govt of India, Punya Salila Srivastava and Pradip Paudel, Minister of Health and Population, Govt of Nepal. Bilateral issues on health such as ensuring affordable drugs, communicable diseases, NCDs, digital health and capacity building of health workforce were discussed,' the Ministry of Health and Family Welfare (MoHFW) stated in a post on X.
'The meeting also reinforced the strong partnership and support shared by India and Nepal,' The MoHFW further noted.
Earlier, India was conferred with the certificate of eliminating Trachoma as a public health problem at the 78th World Health Assembly in Geneva.
Union Health Minister JP Nadda lauded this achievement and said it was a proud moment for the nation.
'A proud moment for the nation at WHA78 (World Health Assembly), India has been conferred the Certificate of Elimination of Trachoma as a Public Health Problem by Tedros Adhanom Ghebreyesus, Director-General at WHO, at the 78th World Health Assembly in Geneva,' Nadda stated in a post on X.
Meanwhile, Prime Minister Narendra Modi virtually addressed the 78th Session of the World Health Assembly in Geneva from New Delhi on Tuesday, highlighting India's contributions to global health initiatives under the unifying theme of 'One World for Health'.
PM Modi mentioned India's Ayushman Bharat scheme, the world's largest health insurance program, which covers 580 million people and provides free treatment.
He outlined three cores for the future of a healthy world - inclusion, integrated vision and collaboration. (ANI)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
5 hours ago
- Business Standard
'Our vaccines are safe': Covishield makers support ICMR-Aiims findings
The Serum Institute of India, the manufacturer of Covishield, has come forward in support of recent studies conducted by the Indian Council of Medical Research (ICMR) and the All India Institute of Medical Sciences (Aiims), which reaffirm the safety of Covid-19 vaccines and their lack of association with sudden cardiac deaths. In a post on X, the Serum Institute of India said, 'In light of recent concerns, we affirm: Two large-scale studies by ICMR and Aiims, as cited by the Ministry of Health [@MoHFW_INDIA] have found no link between Covid-19 vaccines and sudden deaths. The vaccines are safe and scientifically validated.' In light of recent concerns, we affirm: Two large-scale studies by ICMR and AIIMS, as cited by the Ministry of Health (@MoHFW_INDIA) have found no link between COVID-19 vaccines and sudden deaths. The vaccines are safe and scientifically validated. Source: — SerumInstituteIndia (@SerumInstIndia) July 3, 2025 This statement follows the release of major studies led by ICMR and Aiims which concluded that Covid-19 vaccines do not cause sudden deaths in adults. 'No link between vaccines and cardiac deaths' The Ministry of Health and Family Welfare (MoHFW) said multiple agencies investigated the phenomenon of sudden, unexplained deaths across India. The results confirmed no direct causal relationship between these deaths and Covid-19 vaccines. 'Sudden cardiac deaths can result from a wide range of factors, including genetics, lifestyle, pre-existing conditions, and post-Covid complications,' the ministry said in a statement. One of the key investigations, conducted by ICMR's National Institute of Epidemiology, surveyed 47 hospitals between May and August 2023. Titled 'Factors associated with unexplained sudden deaths among adults aged 18-45 years in India', the study concluded that Covid-19 vaccination does not raise the risk of sudden unexplained death among young adults. An Aiims-ICMR study 'Establishing the cause in sudden unexplained deaths in young', suggested that most such fatalities were attributable to heart attacks, genetic predispositions, and poor lifestyle habits. Vaccines critical to public health, says govt Reaffirming the safety profile of vaccines, MoHFW said that data from ICMR and the National Centre for Disease Control show only rare instances of adverse effects. The ministry warned against misinformation that could fuel vaccine hesitancy. 'Statements linking Covid vaccination to sudden deaths are false and misleading,' it said. 'Speculative claims without conclusive evidence undermine public confidence in life-saving immunisation.' MoHFW said that Covid-19 vaccines were instrumental in saving millions of lives and continue to be vital in protecting against severe illness.
Time of India
6 hours ago
- Time of India
'Scientific evidence refutes that Covid vaccines are responsible for sudden deaths': Medical expert
Speaking to ANI, Dr Mohit Gupta, Professor of Cardiology, GB Pant Hospital, said that findings from a study conducted on 1,600 heart attack patients showed a protective benefit of the Covid-19 vaccines. NEW DELHI: Medical experts have rejected allegations that Covid-19 vaccines are responsible for a recent spike in heart attack-related deaths, following comments made by Karnataka Chief Minister Siddaramaiah regarding over twenty such deaths in Hassan district. Speaking to ANI, Dr Mohit Gupta, Professor of Cardiology, GB Pant Hospital, said that findings from a study conducted on 1,600 heart attack patients showed a protective benefit of the Covid-19 vaccines. He said, "In our own study on 1,600 patients with heart attacks who had received the Covid vaccine and those who had not received it. We found that those who have received the Covid vaccine not only have lower chances of having a heart attack, all-cause mortality and sudden deaths, but also, following them for 30 days and 6 months, the chances of death of those people are significantly reduced." "The Covid-19 vaccine is harmless and also plays a protective role. This study is not only ours; ICMR has also validated this. Multiple hospitals have conducted big studies on this. A Korean study on around 2 lakh people replicated the same results. The US Covid Collaboration replicated similar results. In our study, we took both the Covid vaccines and similar results were shown for both the Covaxin and Covishield," he added. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo Refuting any linkage between cardiac deaths and Covid vaccines, Dr Gupta said that scientific evidence refutes that Covid vaccines are responsible for sudden deaths. The doctor stated, "This is a sudden hype. If we see practically too, then we have given this vaccine all over the country, so if that is the case, there will be clustering, multiple deaths will be reported from different parts of the country, which will be significantly increased, but in the last 5 years, nothing such has happened. Suddenly, if there are 4-5 cases and if we think that is because of the vaccine, then no. there are multiple reasons of sudden cardiac death. .. I think we really has to be think over... Scientific evidence refutes that Covid vaccines are responsible for sudden deaths..." Earlier, Kiran Mazumdar Shaw, the Executive Chairperson of Biocon Limited echoed similar sentiments and refuted the allegation of the Karnataka Chief Minister Siddaramaiah, in which he attributed more than twenty deaths due to heart attacks in the past one month in district of Hassan to Covid vaccines. She said that it was factually incorrect to suggest that Covid vaccines were hastily approved. Earlier in a post on X, CM Siddaramaiah shared that in the past month, in just one district of Hassan, more than twenty people died due to heart attacks. CM Siddaramaiah said, "In the past month alone, in just one district of Hassan, more than twenty people have died due to heart attacks. The government is taking this matter very seriously. To identify the exact cause of these series of deaths and to find solutions, a committee of experts has been formed under the leadership of Dr. Ravindranath, Director of Jayadeva Institute of Cardiovascular Sciences and Research, and they have been instructed to submit a study report within 10 days. " He further said that orders were given to this same committee back in February to conduct a thorough study on the reasons behind sudden deaths among young people in the state, and whether the Covid vaccines could have any adverse effects. In this regard, the process of examining and analysing heart patients is also underway. On July 2, a press release by the Union Health Ministry said that studies by the Indian Council of Medical Research (ICMR) and National Centre for Disease Control (NCDC) have established that there is no direct link between Covid-19 vaccination and the reports of sudden deaths in the country.
&w=3840&q=100)
Business Standard
7 hours ago
- Business Standard
Max, Aster DM, Apollo rally up to 7%; what's driving hospital stocks today?
Hospital stocks in focus: Shares of the listed companies engaged in hospital business like Max Healthcare Institute, Aster DM Healthcare and Apollo Hospitals Enterprise have rallied up to 7 per cent, hitting their respective new highs on the BSE in Thursday's intra-day trade on healthy business outlook. Among the individual stocks, Aster DM Healthcare has surged 7 per cent to ₹638.60, on the back of a 20-fold jump in average trading volumes. A combined 16.06 million equity shares representing 3.2 per cent of total equity of the company have changed hands on the NSE and BSE. Shares of Apollo Hospitals Enterprise (₹7,599.75) and Max Healthcare Institute (₹1,308.55) were up 2 per cent on the BSE. Besides these three stocks, Global Health, Fortis Healthcare, Fortis Malar Hospitals, Narayana Hrudayalaya and Yatharth Hospital & Trauma Care Services were up in the range of 1 per cent to 3 per cent. In comparison, the BSE Sensex was up 0.18 per cent at 83,562 at 02:07 PM. What's driving hospital stocks? According to CRISIL MI&A Research, the Indian healthcare delivery industry is projected to experience major growth, with a compound annual growth rate (CAGR) of 9-11 per cent anticipated between fiscal years 2025 and 2027. This growth trajectory is underpinned by several long term structural factors, including rising healthcare needs due to demographic shifts and increasing chronic disease prevalence. Additionally, the industry's strong fundamentals, coupled with improving affordability among the population, are expected to drive demand for healthcare services. Furthermore, the potential impact of initiatives such as the Ayushman Bharat scheme, aimed at providing universal health coverage, is poised to further propel industry growth during this period. With sustained support from long-term structural factors, renewed emphasis on the Pradhan Mantri Jan Arogya Yojana (PMJAY), and heightened Government focus on the healthcare sector, the healthcare delivery market is projected to expand at a CAGR of approximately 9-11 per cent, reaching ₹8.6 trillion by fiscal 2027, Apollo Hospital said in its annual report. Given the major mismatch between demand and supply for quality beds, along with the improved financial health of corporate hospitals following the pandemic, players appear well-positioned to achieve profitable growth as they strengthen their presence in core markets and venture into Tier 2+ areas geographies, CareEdge Ratings said. CareEdge Ratings forecasts that the corporate hospital chains in its coverage will achieve approximately 10-12 per cent year-on-year sales growth in fiscal 2026, driven by a 5-6 per cent increase in Average Revenue Per Occupied Bed (ARPOB), a 100-200 basis point (bps) improvement in occupancy, and rise in new bed additions. With significant untapped market opportunities and a shortage of healthcare infrastructure in India, leading Indian companies have immense potential for expansion. Supported by long-term structural growth factors, renewed momentum from PMJAY, and increased government focus on the healthcare sector, the Indian hospital sector is projected to grow at a CAGR of 10-11 per cent over the next 3-5 years. Key demand drivers include the rise in lifestyle-related diseases, growing medical tourism, increasing incomes, and demographic changes. With limited government capital expenditure and a lack of infrastructure, the private sector is expected to experience accelerated growth in the years to come, CareEdge Ratings said in its March 2025 report.
